We are analyzing https://link.springer.com/article/10.1007/s10549-011-1667-z.

Title:
Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study | Breast Cancer Research and Treatment
Description:
Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women’s Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55–69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61–9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32–9.34], P trend = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75–5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70–6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30–9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41–4.03], P trend = 0.007), axillary radiation (yes vs. no: 1.72 [1.15–2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60–7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, breast, lymphedema, article, google, scholar, pubmed, risk, factors, arm, cas, treatment, study, health, survivors, women, schmitz, oncol, surg, axillary, ahmed, womens, folsom, symptoms, patients, med, privacy, cookies, content, data, research, iowa, epidemiology, related, access, cancerrelated, node, publish, search, prizment, prospective, age, surgery, incidence, year, res, treat, phys, sentinel, ann,

Topics {✒️}

month download article/chapter contemporary population-based study stage i-ii carcinoma early-stage breast cancer breast carcinoma-related lymphedema breast cancer-related lymphedema breast cancer-related lymphedema williams-smith ct full article pdf privacy choices/manage cookies sentinel node biopsy breast cancer patients breast cancer survivors breast cancer surgery lymphedema risk factors breast cancer 5 years sports medicine roundtable breast cancer diagnosis european economic area related subjects axillary surgical care body fat distribution querci della rovere van zee ki long-term morbidity von gruenigen ve randomized controlled trial patients treated conservatively breast cancer treatment developed unilateral bc conditions privacy policy 5-year prospective study updated systematic review secker-walker rh related arm symptoms tumor-positive nodes lymphedema therapy referral accepting optional cookies health study staff obesity poorer general health kushi lh article log schmitz kh article ahmed baseline general health risk factors journal finder publish developing arm lymphedema author information authors

Questions {❓}

Soran A, D’Angelo G, Begovic M, Ardic F, Harlak A, Samuel Wieand H, Vogel VG, Johnson RR (2006) Breast cancer-related lymphedema—what are the significant predictors and how they affect the severity of lymphedema?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study
         description:Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women’s Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55–69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61–9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32–9.34], P trend = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75–5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70–6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30–9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41–4.03], P trend = 0.007), axillary radiation (yes vs. no: 1.72 [1.15–2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60–7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.
         datePublished:2011-07-15T00:00:00Z
         dateModified:2011-07-15T00:00:00Z
         pageStart:981
         pageEnd:991
         sameAs:https://doi.org/10.1007/s10549-011-1667-z
         keywords:
            Lymphedema
            Breast cancer survivors
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:130
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rehana L. Ahmed
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Department of Dermatology, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kathryn H. Schmitz
               affiliation:
                     name:University of Pennsylvania
                     address:
                        name:Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anna E. Prizment
               affiliation:
                     name:The University of Minnesota
                     address:
                        name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aaron R. Folsom
               affiliation:
                     name:The University of Minnesota
                     address:
                        name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study
      description:Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women’s Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55–69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61–9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32–9.34], P trend = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75–5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70–6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30–9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41–4.03], P trend = 0.007), axillary radiation (yes vs. no: 1.72 [1.15–2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60–7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.
      datePublished:2011-07-15T00:00:00Z
      dateModified:2011-07-15T00:00:00Z
      pageStart:981
      pageEnd:991
      sameAs:https://doi.org/10.1007/s10549-011-1667-z
      keywords:
         Lymphedema
         Breast cancer survivors
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:130
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rehana L. Ahmed
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Department of Dermatology, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kathryn H. Schmitz
            affiliation:
                  name:University of Pennsylvania
                  address:
                     name:Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anna E. Prizment
            affiliation:
                  name:The University of Minnesota
                  address:
                     name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aaron R. Folsom
            affiliation:
                  name:The University of Minnesota
                  address:
                     name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:130
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Minnesota
      address:
         name:Department of Dermatology, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Pennsylvania
      address:
         name:Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:The University of Minnesota
      address:
         name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:The University of Minnesota
      address:
         name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rehana L. Ahmed
      affiliation:
            name:University of Minnesota
            address:
               name:Department of Dermatology, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kathryn H. Schmitz
      affiliation:
            name:University of Pennsylvania
            address:
               name:Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Anna E. Prizment
      affiliation:
            name:The University of Minnesota
            address:
               name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Aaron R. Folsom
      affiliation:
            name:The University of Minnesota
            address:
               name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Dermatology, University of Minnesota, Minneapolis, USA
      name:Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA
      name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
      name:Division of Epidemiology and Community Health, The University of Minnesota, Minneapolis, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(128)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.44s.

LINK . SPRINGER . COM {}